Biogenic amines are typically regarded as neuromodulators rather than fast-acting neurotransmitters. In this issue of Neuron, Pirri et al. report the characterization of LGC-55 in C. elegans, the first identified tyraminegated chloride channel. This study suggests that the roles of classical and trace biogenic amines in all organisms may need to be reconsidered.
Chemical signaling in the nervous system is primarily achieved by the action of neuroactive peptides and small-molecule neurotransmitters. Whereas numerous neuroactive peptides have been identified in vertebrates, there appears to be a relatively limited repertoire of small-molecule transmitters. These include acetylcholine; the amino acids glutamate, glycine, and g-aminobutyric acid; and the biogenic amines dopamine, serotonin, norepinephrine, epinephrine, and histamine. However, there is growing evidence that there may be additional amine transmitters. These amines, mainly b-phenylethylamine, tyramine, octopamine, and tryptamine, are structurally and biosynthetically linked to the classical amine transmitters and are collectively referred to as the trace amines, as they are present in only trace amounts in brain tissue.
Despite their low abundance, there is substantial evidence that these trace amines play important physiological roles (Burchett and Hicks, 2006) . In fact, they appear to affect classical biogenic amine signaling both presynaptically, by affecting the synthesis, release, and reuptake of biogenic amines, and postsynaptically, by potentiating the activity of biogenic amines. As such, they have been implicated in a wide range of neuropathological conditions that result from altered biogenic amine signaling. However, the identification of a new family of G protein-coupled receptors (GPCRs), the trace amine-associated receptors (TAARs), suggests that trace amines may also have functions that are entirely independent of the classical biogenic amines (Borowsky et al., 2001; Zucchi et al., 2006) . Indeed, the founding member of the TAAR family, TAAR1, is activated by tyramine and b-phenylethylamine, and not, or much less so, by the classical biogenic amines. But the true endogenous ligands and physiological roles of the TAARs are still unclear.
In contrast to the situation in vertebrates, it is well established that at least two of the trace amines, octopamine and its precursor tyramine, are transmitters in invertebrates and are generally regarded as the invertebrate counterparts to the adrenergic system. The roles of octopamine and tyramine have been particularly well studied in insects, where they have been found to affect a wide spectrum of behaviors, including locomotion, foraging, aggression, and learning (Roeder, 2005) . Although tyramine is the precursor to octopamine, there appear to be distinct tyraminergic and octopaminergic neurons, distinct tyramine and octopamine GPCRs, and, experimentally, exogenous tyramine and octopamine can produce opposite effects indicating that, at least in insects, tyramine can act as a transmitter independently of its conversion into octopamine.
It has been known for a long time that exogeneous octopamine can have behavioral effects in the nematode C. elegans, but the role of tyramine has been studied only recently. In general, octopamine and tyramine have effects that are antagonistic to serotonin. For example, exogenous octopamine or tyramine causes hyperactivity, suppresses pharyngeal pumping, suppresses egg-laying, and inhibits responses to aversive stimuli (Chase and Koelle, 2007; Wragg et al., 2007) . At first glance, it may seem that tyramine could be acting through its conversion to octopamine, but this seems not to be the case.
The study of genes encoding the biosynthetic enzymes of tyramine and octopamine has provided key insights on this issue (Alkema et al., 2005) . The amino acid tyrosine is converted into tyramine by the action of tyrosine decarboxylase, which in turn is converted into octopamine by the action of tyramine b-hydroxylase. These enzymes are encoded by the C. elegans genes tdc-1 and tbh-1, respectively. In a recent study using specific antibodies, Alkema et al. found that TDC-1 and TBH-1 are coexpressed in a pair of interneurons in the head of the worm (the RIC neurons) and in three pairs of contractile myoepithelial cells that are involved in ovulation (the gonad sheath cells). The coexpression of the two enzymes in these cells suggests that they are octopaminergic. Interestingly, they also found that TDC-1 is expressed at high levels in some cells that do not express TBH-1. These cells include a pair of motorneurons (the RIM neurons) and four uterine cells that are endocrine cells (the uv1 cells). The lack of expression of TBH-1 in these cells suggests that they are tyraminergic. Moreover, Alkema et al. found that mutation of tdc-1 confers phenotypes that are not produced by mutation of tbh-1. In particular, they found that tdc-1 mutants have a hyperactive egg-laying phenotype, suggesting that tyramine released from the uv1 cells somehow affects the activity of the neural circuit controlling the egglaying behavior. In addition, they identified roles for tyramine in rather subtle locomotory phenotypes. C. elegans locomotion alternates between long stretches of forward locomotion and brief bouts of backward locomotion (or spontaneous reversals). Locomotion is accompanied by head movements during which the tip of the nose oscillates from side to side. This is believed to represent an exploratory or foraging behavior. Body movements are controlled by body wall muscles, whereas head movements are controlled by head and neck muscles, and thus the two types of movement are controlled independently. A light touch to the anterior half of the body causes worms to reverse and to suppress head oscillations. In tdc-1 mutants, head oscillations are not suppressed during light-touchinduced reversals. In addition, tdc-1 mutants exhibit higher rates of spontaneous reversals but shorter lengths of reversals.
By consulting the C. elegans wiring diagram, Alkema et al. suggest how this could be achieved. The tyraminergic RIM neurons are coupled by gap junctions to the AVA command neurons, which are coupled electrically to the AVD command neurons, which receive synaptic inputs from the anterior touch sensory neurons ALM and AVM. The RIM neurons make synaptic connections with the head muscles and with the cholinergic RMD and SMD motorneurons, which innervate the head muscle. This suggested a model where RIM neurons are activated by anterior touch through gap junctions with AVA, which leads to the release of tyramine, the relaxation of head muscles, and the suppression of head oscillations. Consistent with the model, laser ablation of the AVA and AVD command neurons recapitulates the defect in head oscillations seen in the tdc-1 mutants. In addition, the RIM neurons make synaptic connections with the AVB neuron, which is a command neuron for forward locomotion. This suggested that tyramine released from the RIM neuron could inhibit AVB and thereby perturb the balance between forward and backward locomotion. However, without the localization of tyramine receptors on the presumed postsynaptic cells, it was difficult to confirm the model.
Around the same time as the characterization of tdc-1 mutants, the Komuniecki lab characterized the first tyramine receptor in C. elegans, SER-2 (Rex et al., 2004) . Like tdc-1 mutants, ser-2 mutants fail to suppress head oscillations during light anterior touch-induced reversals. However, SER-2 is not expressed in any of the neurons that are postsynaptic to RIM, suggesting that tyramine acts extrasynaptically on these receptors. Since then, additional tyramine and octopamine receptors have been identified, none of which appear to be expressed in cells that are postsynaptic to RIM. This suggested that either the model was incorrect or that there were additional, as yet unidentified, tyramine receptors.
A paper in this issue of Neuron addresses this question with conclusive results. Pirri et al. (2009) discovered that relatively high concentrations of tyramine cause paralysis in worms within 5 min of exposure. In order to find effectors of tyramine, they carried out a forward genetic screen to find mutants that were resistant to this paralytic effect. They identified two separate mutants that affect the same gene, lgc-55, which encodes a cys-loop ligand gated ion channel (LGIC).
LGC-55 expressed in Xenopus oocytes is activated by octopamine, dopamine, and weakly by serotonin, but is most potently activated by tyramine, suggesting that tyramine could be its endogenous ligand. Moreover, lgc-55 mutants have phenotypes that overlap with those of tdc-1 mutants, including a failure to suppress head oscillations in response to touch to the anterior part of the worm, an increased rate of reversal, and decreased lengths of reversals. This provides strong evidence that LGC-55 is a tyramine receptor and, thus, is the first example of an ionotropic tyramine receptor.
But does LGC-55 act in cells that are postsynaptic to RIM, as predicted from the wiring diagram? Using GFP reporter constructs, Pirri et al. show that LGC-55 is expressed in neck muscles, the RMD and SMD motorneurons, and the AVB forward locomotion command neuron, as well as in additional neurons. By expressing LGC-55 in different subsets of the cells in which it is normally expressed, Pirri et al. find that expression of LGC-55 in neck muscles is required for the suppression of head oscillations in response to anterior touch and that expression of LGC-55 in the AVB forward command neuron is required for wild-type reversal frequency and duration. Thus, tyramine released from the RIM neurons acts on two distinct synaptic partners via LGC-55: it acts on the neck muscles to suppress head oscillations and it acts on the AVB forward command neuron to promote backward locomotion. In both cases, RIM appears to be inhibiting its postsynaptic partner.
How could LGC-55 exert its inhibitory effects? Sequence analysis suggested that LGC-55 might be an anion-selective channel. Pirri et al. have confirmed this directly with heterologous expression of LGC-55 in C. elegans muscle and in Xenopus oocytes. In both cases, they observed tyramine-activated currents with reversal potentials similar to that reported for other C. elegans chlorideselective channels. Moreover, the reversal potential of the Xenopus currents could be shifted in response to changes in chloride ion concentrations. These experiments confirm that lgc-55 encodes a tyramine-gated chloride channel and that in vivo tyramine can act synaptically as a classical fast inhibitory neurotransmitter.
It is worth noting that the vast majority of known biogenic amine receptors are metabotropic; that is, they exert their effects via slow G protein-mediated responses. However, the assumption that monoamines function only as neuromodulators may reflect a mammalian/vertebrate bias. For example, whereas only GABA and glycine are known to act through ligandgated anion channels in vertebrates, in C. elegans, anion channels gated by serotonin (Ranganathan et al., 2000) , glutamate (Dent et al., 1997) , acetylcholine (Ranganathan et al., 2000) , as well as tyramine have been described. The C. elegans genome has the largest cys-loop LGIC superfamily characterized thus far, which includes many whose ligands remain unidentified (Jones and Sattelle, 2008) ; thus, it is not unreasonable to suppose that all monoamines might function as fast inhibitory and/or excitatory neurotransmitters in this organism. With a simple nervous system of only 302 neurons, one way to increase flexibility is to increase complexity at the neurochemical level. The expansion of the LGIC superfamily suggests that C. elegans may be achieving this in part by evolving an expanded repertoire of transmitter receptors.
Studies such as this suggest a number of intriguing questions regarding the functions of biogenic amines and their mechanisms of action. How common are biogenic amine-gated ion channels in other animal groups, and how conserved are they at the molecular level? Could tyramine and other trace amines act as bona fide synaptic neurotransmitters in other animals, including vertebrates? Are there additional biogenic amines that function in neuronal signaling that have yet to be identified? A wider examination of the roles of biogenic amines in animal nervous systems is likely to shed light on both the conservation and diversity of neuronal signal transduction mechanisms.
